Global Cardiac Mapping Market

Cardiac Mapping Market: Insights

The overall cardiac mapping market will be led by a significant compound annual growth rate over the estimated period from 2020 to 2026. One of the highly sophisticated techniques associated with the processing and presentation of electrocardiogram data is cardiac mapping. By extracting and showing information from the cardiac electrogram, it is used to diagnose heart rhythms. The collected information is transmitted to the software, where a 3-dimensional (3D) heart model is developed, showing the electrical waves emitted during each heartbeat. The rising prevalence of target diseases and the emerging geriatric population are some of the key elements expected to foster growth in the Cardiac Mapping industry. The implementation by medical device companies of various advanced diagnostic technologies, the increase in demand for accurate diagnosis of essential cardiac diseases, and the availability in developing economies of well-qualified interventional cardiologists are expected to increase the development of the business for cardiac mapping systems during the forecast period. Moreover, the growth of the industry is also driven by increased demand from patients for cost-effective diagnosis and care for cardiovascular disorders and improved reimbursement policies worldwide. However, the administration's lack of experience and qualified professionals and strict standards by the government is likely to adversely impede business growth over the planned timeframe.

Cardiac Mapping Market: By Type

Based on type, the market is segmented into non-contact cardiac mapping systems and contact cardiac mapping systems. It is projected that the contact cardiac mapping systems group will lead to a substantial growth trend in this business sector from 2020 to 2026. Technologically, contact mapping systems are more effective and reliable, thus offering greater precision, sensitivity, and reliability in the diagnosis and ablation of diseases. Subsequently, there is also an increasing need for cardiac mapping devices to diagnose complex arrhythmias.

Cardiac Mapping Market: By Indication

Following the indication study, this market can be supported by four categories: atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (ACNRT), and other arrhythmias. Atrial fibrillation is expected to contribute most to the sector's global revenue. This is due to the increasing incidence of AF across the globe and related ablation procedures. The era of technical developments in mapping systems around the world is further stimulating the market's success.

Cardiac Mapping Market: By Region

The market for cardiac mapping is partitioned into Europe, APAC, North America, CSA, and MEA, depending on the geographical location. Over the projected period, the North American area is expected to add majorly to global revenues. This is due to the high incidence of CVDs, the increase in the acceptance rate of the U.S. cardiac mapping systems, and clinical trials validating cardiac mapping systems, which are expected to stimulate demand growth over the projected timeframe in the market of North America. Moreover, the development of the region is driven by the growing focus of government organizations on providing funding for research and the increasing geriatric population in Canada. Furthermore, the Asia-Pacific region is projected to see significant growth at a rapid CAGR level in major markets. This is attributable to an optimized scenario and rising government healthcare strategies to promote business growth.

Cardiac Mapping Market Share & Competitor Analysis

The key players competing in this market are Abbott Laboratories, Boston Scientific Corporation, EP Solutions Sa, Koninklijke Philips N.V., Biotronik, Biosig Technologies, Inc., Coremap Catheter Precision, Inc., Biosense Webster, Inc. (A Johnson & Johnson Company), Medtronic Plc, Microport Scientific Corporation, Acutus Medical, Lepu Medical, Angiodynamics, APN Health, LLC, Kardium, Inc., and Epmap-System, among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In May 2019, Acutus medical entered into a partnership with Peerbridge Health. It provided its advanced outpatient ECG, Peerbridge Cor, which has been cleared to classify up to 26 separate arrhythmias to be used with the AcQMap method.